Noxopharm Ltd has released a press release.
Breakthrough in Delivering Idronoxil into Brain
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Earlier from Noxopharm
- Initial Clinic Study Announced and Approved
- Amendment to Preliminary Final Report
- Preliminary Final Report
- Noxopharm to Initiate Radiotherapy Clinical Studies
- Noxopharm Provides Update on Inaugural Clinical Study
Later from Noxopharm
- First NOX66 Clinical Trial to Commence
- Brain Cancer Study Commences
- NOX researching rare Abscopal Response
- Noxopharm and UNSW combine on stroke project
- NOX and Monash Uni Collaboration Receives Federal Grant
Follow Noxopharm into a list and get an email when it puts out news.
Follow Noxopharm